Unknown

Dataset Information

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.


ABSTRACT:

Background

Continued dual antiplatelet therapy and optimal medical therapy (OMT) improve outcomes in selected patient populations with established coronary heart disease, but whether OMT modifies the treatment effect of dual antiplatelet therapy is unknown.

Methods

The DAPT (Dual Antiplatelet Therapy) Study, a double-blind trial, randomly assigned 11 648 patients who had undergone coronary stenting and completed 1 year of dual antiplatelet therapy without major bleeding or ischemic events to an additional 18 months of continued thienopyridine or placebo. OMT was defined as a combination of statin, β-blocker, and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use in patients with an American College of Cardiology/American Heart Association class I indica

SUBMITTER: Resor CD 

PROVIDER: S-EPMC5421387 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature